National HealthCare Q3 2026 Revenue Rises 3.9% to $397.4M

National HealthCare (NHC) reported results for the third quarter of 2026. Revenue was $397.4 million, up 3.9% from a year earlier, and adjusted EPS was $0.87, down 45% from a year earlier.

By our calculation, the QoQ column compares with the previous quarter's revenue of $408.0 million and adjusted EPS of $2.54. The YoY column compares with $382.7 million and $1.58 in the same quarter a year earlier.

GAAP results

• GAAP EPS. GAAP diluted EPS was $0.85, against $2.50 a year earlier.
• Net income. The company reported net income of $13.6 million on a GAAP basis, compared with net income of $39.2 million a year earlier.

Track record

• Revenue trend. Revenue over the last 5 reports, oldest first: $382.7 million, $386.5 million, $381.8 million, $408.0 million and $397.4 million.

What to watch

• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 3.9% increase to $397.4 million.
• Sequential trend. Whether revenue builds on its 2.6% decrease from the previous quarter.
• Related coverage. See our reports on Pacira BioSciences, Celldex Therapeutics, Interface and Brighthouse Financial.

Sources: Results are from National HealthCare's Nov. 6, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from National HealthCare's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.